Literature DB >> 16686600

Id-1 modulates senescence and TGF-beta1 sensitivity in prostate epithelial cells.

Kaijun Di1, Ming-Tat Ling, Sai Wah Tsao, Yong Chuan Wong, Xianghong Wang.   

Abstract

BACKGROUND INFORMATION: Loss of sensitivity to TGF-beta1 (transforming growth factor beta1)-induced growth arrest is an important step towards malignant transformation in human epithelial cells, and Id-1 (inhibitor of differentiation or DNA binding-1) has been associated with cell proliferation and cell-cycle progression. Here, we investigated the role of Id-1 in cellular sensitivity to TGF-beta1.
RESULTS: Using an immortalized prostate epithelial cell line, NPTX cells, we suppressed Id-1 expression through antisense strategy. We found that inhibition of Id-1 expression suppressed cell proliferation and at the same time induced cellular senescence and G2/M cell-cycle arrest. In addition, inactivation of Id-1 made cells more vulnerable to TGF-beta1-induced growth arrest. The sensitization effect on TGF-beta1 was associated with up-regulation of two downstream effectors of the TGF-beta1 pathway, p21WAF1/Cip1 and p27KIP1.
CONCLUSION: Our results indicate that endogenous Id-1 levels might be a crucial factor in the development of resistance to TGF-beta1-induced growth suppression in human prostate epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16686600     DOI: 10.1042/BC20060026

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  15 in total

1.  Id-1 expression and prognosis in cancer: do antibodies matter?

Authors:  Ignacio Gil-Bazo; Mariano Ponz-Sarvisé; Angel Panizo-Santos; Alfonso Calvo
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

2.  ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21.

Authors:  Hao Geng; Brooks L Rademacher; Janet Pittsenbarger; Chung-Ying Huang; Christopher T Harvey; Marie C Lafortune; Anne Myrthue; Mark Garzotto; Peter S Nelson; Tomasz M Beer; David Z Qian
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

3.  TGF-β1-induced expression of Id-1 is associated with tumor progression in gastric cancer.

Authors:  Huiying Ma; Ye Wei; Yongmei Leng; Shichao Li; Lingling Gao; Heng Hu; Long Chen; Fei Wang; Honglei Xiao; Chouwen Zhu; Chunmin Liang
Journal:  Med Oncol       Date:  2014-05-27       Impact factor: 3.064

4.  A dormant state modulated by osmotic pressure controls clonogenicity of prostate cancer cells.

Authors:  Maryline Havard; François Dautry; Thierry Tchénio
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

Review 5.  Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses?

Authors:  Corinne Abbadie; Olivier Pluquet; Albin Pourtier
Journal:  Cell Mol Life Sci       Date:  2017-07-13       Impact factor: 9.261

6.  [Transforming growth factor β in prostate cancer: cellular effects and basic molecular mechanisms].

Authors:  M B Stope; C Rönnau; T Schubert; D Staar; J Bradl; P Ziegler; A Streitbörger; N Kroeger; U Zimmermann; R Walther; M Burchardt; C Börgermann
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

Review 7.  TGF-β1 Signaling and Tissue Fibrosis.

Authors:  Kevin K Kim; Dean Sheppard; Harold A Chapman
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

8.  Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.

Authors:  Nicole Strong; Ana C Millena; Lindsey Walker; Jaideep Chaudhary; Shafiq A Khan
Journal:  Prostate       Date:  2012-10-11       Impact factor: 4.104

Review 9.  The aging lacrimal gland: changes in structure and function.

Authors:  Eduardo M Rocha; Monica Alves; J David Rios; Darlene A Dartt
Journal:  Ocul Surf       Date:  2008-10       Impact factor: 5.033

10.  Prostate cancer-associated gene expression alterations determined from needle biopsies.

Authors:  David Z Qian; Chung-Ying Huang; Catherine A O'Brien; Ilsa M Coleman; Mark Garzotto; Lawrence D True; Celestia S Higano; Robert Vessella; Paul H Lange; Peter S Nelson; Tomasz M Beer
Journal:  Clin Cancer Res       Date:  2009-04-14       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.